Healthcare -
Biotechnology - NASDAQ - US
$ 9.865
-2.23 %
$ 1.02 B
Market Cap
-1.88
P/E
NTLA - TOTAL RECEIVABLES
Total Receivables NTLA - Intellia Therapeutics, Inc.
36.5 M
LAST VALUE
323.67%
2 YEAR CAGR
37.02%
5 YEAR CAGR
0.00%
10 YEAR CAGR